NYSE:AET - Aetna Stock Price, Price Target & More

Get Started

$178.54 +1.42 (+0.80 %)

(As of 05/27/2018 06:04 AM ET)

Previous Close$178.54

Today's Range$176.4950 - $178.6050

52-Week Range$142.66 - $194.40

Volume953,127 shs

Average Volume1.97 million shs

Market Capitalization$58.40 billion

P/E Ratio17.32

Dividend Yield1.12%

Beta0.64

About Aetna (NYSE:AET)

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.

Receive AET News and Ratings via Email

Sign-up to receive the latest news and ratings for AET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans

Sub-IndustryManaged Health Care

SectorMedical

SymbolNYSE:AET

CUSIP00817Y10

Webwww.aetna.com

Phone860-273-0123

Debt

Debt-to-Equity Ratio0.47

Current Ratio0.73

Quick Ratio0.73

Price-To-Earnings

Trailing P/E Ratio17.32

Forward P/E Ratio16.14

P/E Growth1.51

Sales & Book Value

Annual Sales$60.54 billion

Price / Sales0.96

Cash Flow$12.4418 per share

Price / Cash14.35

Book Value$50.95 per share

Price / Book3.50

Profitability

EPS (Most Recent Fiscal Year)$9.86

Net Income$1.90 billion

Net Margins5.76%

Return on Equity21.42%

Return on Assets5.99%

Miscellaneous

Employees47,950

Outstanding Shares327,100,000

Aetna (NYSE:AET) Frequently Asked Questions

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna announced a quarterly dividend on Friday, May 18th. Shareholders of record on Wednesday, July 25th will be paid a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Tuesday, July 24th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna declared that its Board of Directors has initiated a share repurchase program on Friday, April 7th 2017, which authorizes the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 98% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna (NYSE:AET) issued its earnings results on Tuesday, May, 1st. The company reported $3.19 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.97 by $0.22. The company earned $15.34 billion during the quarter, compared to analysts' expectations of $15.32 billion. Aetna had a return on equity of 21.42% and a net margin of 5.76%. Aetna's quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.71 earnings per share. View Aetna's Earnings History.

When is Aetna's next earnings date?

Aetna is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Aetna.

What price target have analysts set for AET?

13 Wall Street analysts have issued 12-month target prices for Aetna's shares. Their forecasts range from $171.00 to $212.00. On average, they anticipate Aetna's stock price to reach $197.3077 in the next year. View Analyst Ratings for Aetna.

Who are some of Aetna's key competitors?

Some companies that are related to Aetna include UnitedHealth Group (UNH), Anthem (ANTM), CIGNA (CI), Humana (HUM), Centene (CNC), WellCare (WCG), Molina Healthcare (MOH), Trupanion (TRUP) and Comprehensive Care (CHCR).

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

Mr. Mark Thomas Bertolini, Chairman & CEO (Age 61)
Ms. Karen Sue Lynch, Pres (Age 55)
Mr. Shawn Michael Guertin, Exec. VP, CFO & Chief Enterprise Risk Officer (Age 54)
Mr. Thomas J. Sabatino Jr., Exec. VP & Gen. Counsel (Age 59)
Ms. Margaret M. McCarthy, Exec. VP of Operations & Technology (Age 64)

Has Aetna been receiving favorable news coverage?

Headlines about AET stock have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aetna earned a news impact score of 0.04 on Accern's scale. They also gave media stories about the company an impact score of 45.99 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Aetna's major shareholders?

Aetna's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.17%), Farallon Capital Management LLC (1.74%), Northern Trust Corp (1.15%), OZ Management LP (1.07%), OppenheimerFunds Inc. (0.96%) and Wells Fargo & Company MN (0.86%). Company insiders that own Aetna stock include Francis S Soistman Jr, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Which institutional investors are selling Aetna stock?

AET stock was sold by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., BlackRock Inc., Westwood Holdings Group Inc., State of Tennessee Treasury Department, Swiss National Bank, Victory Capital Management Inc., Eaton Vance Management and Legal & General Group Plc. Company insiders that have sold Aetna company stock in the last year include Karen S Lynch and Margaret M Mccarthy. View Insider Buying and Selling for Aetna.

Which institutional investors are buying Aetna stock?

AET stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Wells Fargo & Company MN, Abrams Capital Management L.P., Alpine Associates Management Inc., Canyon Capital Advisors LLC, PointState Capital LP, Omni Partners LLP and Farallon Capital Management LLC. View Insider Buying and Selling for Aetna.

How do I buy shares of Aetna?

Shares of AET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of AET stock can currently be purchased for approximately $178.54.

How big of a company is Aetna?

Aetna has a market capitalization of $58.40 billion and generates $60.54 billion in revenue each year. The company earns $1.90 billion in net income (profit) each year or $9.86 on an earnings per share basis. Aetna employs 47,950 workers across the globe.

How can I contact Aetna?

Aetna's mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company can be reached via phone at 860-273-0123 or via email at [email protected]

MarketBeat Community Rating for Aetna (AET)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		717 (Vote Outperform)
Underperform Votes:		490 (Vote Underperform)
Total Votes:		1,207

MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe AET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AET will underperform the S&P 500 over the long term. You may vote once every thirty days.

Aetna (NYSE:AET) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

13 Wall Street analysts have issued ratings and price targets for Aetna in the last 12 months. Their average twelve-month price target is $197.3077, suggesting that the stock has a possible upside of 10.51%. The high price target for AET is $212.00 and the low price target for AET is $171.00. There are currently 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.54	2.61	2.65	2.62
Ratings Breakdown:	0 Sell Rating(s) 6 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 7 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 7 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$197.3077	$189.8235	$189.8235	$174.6471
Price Target Upside:	10.51% upside	1.27% upside	1.27% upside	2.03% upside

Aetna (NYSE:AET) Consensus Price Target History

Price Target History for Aetna (NYSE:AET)

Aetna (NYSE:AET) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/14/2018	Credit Suisse Group	Lower Price Target	Neutral ➝ Neutral	$208.00 ➝ $194.00	Low
5/1/2018	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight		Medium
1/31/2018	Jefferies Group	Reiterated Rating	Hold	$205.00	Low
1/31/2018	Citigroup	Downgrade	Buy ➝ Neutral	$187.89 ➝ $212.00	Low
1/30/2018	Cowen	Reiterated Rating	Buy	$212.00	Low
1/30/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$212.00	Low
1/22/2018	Deutsche Bank	Upgrade	Hold ➝ Buy	$195.00 ➝ $212.00	Low
12/20/2017	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$179.00	Low
12/6/2017	Argus	Downgrade	Buy ➝ Hold	$185.00	Low
12/4/2017	Wells Fargo & Co	Reiterated Rating	Outperform	$200.00 ➝ $208.00	High
11/3/2017	Raymond James	Upgrade	Market Perform ➝ Outperform	$200.00	N/A
10/27/2017	BMO Capital Markets	Boost Price Target	Market Perform	$175.00 ➝ $200.00	N/A
8/4/2017	Royal Bank of Canada	Boost Price Target	Outperform ➝ Outperform	$162.00 ➝ $171.00	Medium
5/17/2017	UBS	Reiterated Rating	Buy	$147.00 ➝ $160.00	N/A
5/17/2017	Bank of America	Reiterated Rating	Buy	$160.00 ➝ $168.00	Medium
5/16/2017	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$150.00 ➝ $158.00	Low
5/15/2017	Barclays	Reiterated Rating	Overweight	$162.00	Low
5/11/2017	Cleveland Research	Upgrade	Neutral ➝ Buy		Low
4/3/2017	CIBC	Reiterated Rating	Outperform		Low
3/31/2017	Oppenheimer	Reiterated Rating	Outperform		Low
1/31/2017	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform		N/A
1/24/2017	Leerink Swann	Downgrade	Outperform ➝ Market Perform	$135.00	N/A
9/22/2016	Evercore ISI	Initiated Coverage	Buy	$128.00	N/A
8/17/2016	FBR & Co	Reiterated Rating	Hold		N/A
7/21/2016	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		N/A

(Data available from 5/27/2016 forward)

Aetna (NYSE:AET) Earnings History and Estimates Chart

Earnings by Quarter for Aetna (NYSE:AET)

Aetna (NYSE:AET) Earnings Estimates

2018 EPS Consensus Estimate: $10.97
2019 EPS Consensus Estimate: $12.18

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$2.95	$3.18	$3.05
Q2 2018	4	$2.94	$3.32	$3.18
Q3 2018	3	$2.78	$2.88	$2.82
Q4 2018	3	$1.71	$2.28	$1.92
Q1 2019	2	$3.41	$3.46	$3.44
Q2 2019	2	$3.61	$3.63	$3.62
Q3 2019	2	$3.11	$3.14	$3.13
Q4 2019	2	$1.94	$2.05	$2.00

Aetna (NYSE AET) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/1/2018		$3.22					N/A
5/1/2018	Q1 2018	$2.97	$3.19	$15.3246 billion	$15.3350 billion	View	N/A
1/30/2018	Q4 2017	$1.18	$1.25	$14.7884 billion	$14.7420 billion	View	N/A
10/31/2017	Q3 2017	$2.06	$2.45	$15.1197 billion	$14.9940 billion	View	N/A
8/3/2017	Q2 2017	$2.34	$3.42	$15.3354 billion	$15.5230 billion	View	Listen
5/2/2017	Q1 2017	$2.36	$2.71	$15.3893 billion	$15.1650 billion	View	Listen
1/31/2017	Q416	$1.44	$1.63	$15.84 billion	$15.73 billion	View	Listen
10/27/2016	Q316	$2.02	$2.07	$15.71 billion	$15.78 billion	View	Listen
8/2/2016	Q216	$2.12	$2.21	$15.69 billion	$15.95 billion	View	Listen
4/28/2016	Q116	$2.23	$2.30	$15.46 billion	$15.69 billion	View	Listen
2/1/2016	Q415	$1.21	$1.37	$14.93 billion	$15.09 billion	View	Listen
10/29/2015	Q315	$1.77	$1.90	$15.22 billion	$15.00 billion	View	Listen
8/4/2015	Q215	$1.82	$2.05	$15.43 billion	$15.13 billion	View	Listen
4/28/2015	Q115	$1.96	$2.39	$15.48 billion	$15.09 billion	View	Listen
2/3/2015	Q414	$1.22	$1.22	$14.59 million	$14.77 million	View	Listen
10/28/2014	Q214	$1.58	$1.79	$14.63 billion	$14.70 billion	View	Listen
7/29/2014	Q114	$1.61	$1.69	$13.98 billion	$14.50 billion	View	Listen
4/24/2014	Q413	$1.56	$1.98	$13.69 billion	$13.97 billion	View	Listen
2/6/2014	Q313	$1.36	$1.34	$13.14 billion	$13.13 billion	View	Listen
10/29/2013	Q213	$1.53	$1.53	$12.89 billion	$12.99 billion	View	Listen
7/30/2013	Q2 2013	$1.39	$1.52	$12.02 billion	$11.56 billion	View	Listen
4/30/2013	Q1 2013	$1.38	$1.50	$9.65 billion	$9.51 billion	View	Listen
1/31/2013	Q4 2012	$0.96	$0.94	$8.97 billion	$8.96 billion	View	Listen
10/25/2012	Q312	$1.34	$1.55	$8.96 billion	$8.90 billion	View	N/A
7/31/2012		$1.25	$1.31			View	N/A
4/26/2012		$1.39	$1.34			View	N/A
2/1/2012		$0.96	$0.97			View	N/A
10/27/2011		$1.14	$1.40			View	N/A
7/27/2011		$1.07	$1.35			View	N/A
4/28/2011		$0.97	$1.43			View	N/A
2/4/2011		$0.62	$0.63			View	N/A
11/3/2010	Q3 2010	$0.67	$0.84			View	N/A
7/27/2010	Q2 2010	$0.73	$1.05			View	N/A
4/29/2010	Q1 2010	$0.72	$0.77			View	N/A
2/5/2010	Q4 2009	$0.42	$0.40			View	N/A
10/29/2009	Q3 2009	$0.66	$0.69			View	N/A
7/27/2009	Q2 2009	$0.79	$0.69			View	N/A
4/29/2009	Q1 2009	$0.93	$0.96			View	N/A
2/12/2009	Q4 2008	$0.95	$0.96			View	N/A
10/29/2008	Q3 2008	$1.12	$1.12			View	N/A
7/31/2008	Q2 2008	$0.93	$0.94			View	N/A
4/24/2008	Q1 2008	$0.92	$0.92			View	N/A
2/7/2008	Q4 2007	$0.88	$0.88			View	N/A

(Earnings results data provided by Zacks Investment Research)

Aetna (NYSE:AET) Dividend Information

Aetna pays an annual dividend of $2.00 per share, with a dividend yield of 1.12%. AET's next quarterly dividend payment will be made on Wednesday, August 1. Aetna pays out 20.28% of its earnings out as a dividend.

Next Dividend:	8/1/2018
Annual Dividend:	$2.00
Dividend Yield:	1.12%
Dividend Growth:	24.80% (3 Year Average)
Payout Ratio(s):	20.28% (Trailing 12 Months of Earnings) 18.08% (Based on This Year's Estimates) 16.38% (Based on Next Year's Estimates) 16.07% (Based on Cash Flow)
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Aetna (NYSE:AET)

Aetna (NYSE:AET) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/18/2018	quarterly	$0.50	1.13%	7/24/2018	7/25/2018	8/1/2018
2/23/2018	quarterly	$0.50	1.13726828158763%	4/11/2018	4/12/2018	4/27/2018
12/4/2017	quarterly	$0.50	1.12%	1/10/2018	1/11/2018	1/26/2018
9/29/2017	quarterly	$0.50	1.25%	10/11/2017	10/12/2017	10/27/2017
5/19/2017	quarterly	$0.50	1.42%	7/11/2017	7/13/2017	7/28/2017
2/17/2017	quarterly	$0.50	1.58%	4/11/2017	4/13/2017	4/28/2017
12/2/2016	quarterly	$0.25	0.77%	1/10/2017	1/12/2017	1/27/2017
9/30/2016	quarterly	$0.25	0.87%	10/11/2016	10/13/2016	10/28/2016
5/20/2016	quarterly	$0.25	0.91%	7/12/2016	7/14/2016	7/29/2016
2/19/2016	quarterly	$0.25	0.94%	4/12/2016	4/14/2016	4/29/2016
12/4/2015	quarterly	$0.25	0.97%	1/12/2016	1/14/2016	1/29/2016
9/25/2015	quarterly	$0.25	0.95%	10/13/2015	10/15/2015	10/30/2015
5/15/2015	quarterly	$0.25	0.88%	7/14/2015	7/16/2015	7/31/2015
2/27/2015	quarterly	$0.25	1%	4/7/2015	4/9/2015	4/24/2015
11/21/2014	quarterly	$0.25	1.15%	1/13/2015	1/15/2015	1/30/2015
9/19/2014	quarterly	$0.2250	1.08%	10/14/2014	10/16/2014	10/31/2014
5/30/2014	quarterly	$0.2250	1.16%	7/8/2014	7/10/2014	7/25/2014
2/28/2014	quarterly	$0.2250	1.25%	4/8/2014	4/10/2014	4/25/2014
12/6/2013	quarterly	$0.2250	1.35%	1/14/2014	1/16/2014	1/31/2014
9/27/2013	quarterly	$0.20	1.25%	10/8/2013	10/10/2013	10/25/2013
5/17/2013	quarterly	$0.20	1.35%	7/9/2013	6/11/2013	7/26/2013
2/19/2013	quarterly	$0.20	1.66%	4/9/2013	4/11/2013	4/26/2013

(Data available from 1/1/2013 forward)

Aetna (NYSE AET) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.21%
Institutional Ownership Percentage: 84.19%

Insider Trading History for Aetna (NYSE:AET)

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Aetna (NYSE AET) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/18/2017	Karen S Lynch	President	Sell	15,271	$161.91	$2,472,527.61	64,261
9/15/2017	Margaret M Mccarthy	EVP	Sell	10,288	$162.85	$1,675,400.80	33,563
6/7/2017	Margaret M Mccarthy	EVP	Sell	27,028	$149.23	$4,033,388.44	33,563
5/17/2017	Mark T Bertolini	Chairman	Sell	103,547	$140.79	$14,578,382.13	659,888
3/23/2017	Shawn M Guertin	Insider	Sell	29,602	$129.35	$3,829,018.70	44,880
3/8/2017	Francis S Soistman Jr	VP	Sell	6,607	$131.98	$871,991.86	23,454
9/7/2016	Jeffrey E. Garten	Director	Sell	7,100	$116.51	$827,221.00
8/23/2016	Shawn M Guertin	Insider	Sell	45,328	$120.21	$5,448,878.88	44,883
5/10/2016	Margaret M Mccarthy	EVP	Sell	39,169	$114.45	$4,482,892.05	56,240
5/3/2016	Mark T Bertolini	CEO	Sell	33,510	$114.00	$3,820,140.00	496,588
3/15/2016	Gary W Loveman	EVP	Buy	8,970	$111.45	$999,706.50	9,605
2/22/2016	Molly Joel Coye	Director	Sell	1,175	$106.28	$124,879.00	8,104
12/23/2015	Margaret M Mccarthy	EVP	Sell	18,373	$109.97	$2,020,478.81	63,515
12/22/2015	Mark T. Bertolini	CEO	Sell	26,996	$110.00	$2,969,560.00	729,194
8/14/2015	Joseph M Zubretsky	EVP	Sell	179,087	$118.66	$21,250,463.42
8/13/2015	Franklin Barbara Hackman	Director	Sell	2,064	$118.47	$244,522.08
3/31/2015	Joseph M Zubretsky	EVP	Sell	200,000	$107.96	$21,592,000.00
3/27/2015	Joseph M Zubretsky	EVP	Sell	86,958	$107.24	$9,325,375.92
3/26/2015	Joseph M Zubretsky	Insider	Sell	162,066	$106.98	$17,337,820.68
3/26/2015	Margaret M Mccarthy	EVP	Sell	27,670	$106.04	$2,934,126.80
3/25/2015	Franklin Barbara Hackman	Director	Sell	3,000	$108.75	$326,250.00
3/17/2015	William James Casazza	VP	Sell	14,000	$105.07	$1,470,980.00
3/2/2015	Molly Joel Coye	Director	Sell	2,500	$100.27	$250,675.00
2/10/2015	Rajan Parmeswar	VP	Sell	5,300	$95.60	$506,680.00
6/16/2014	Molly Joel Coye	Director	Sell	1,650	$80.60	$132,990.00
6/12/2014	William James Casazza	VP	Sell	15,906	$80.58	$1,281,705.48
5/27/2014	Franklin Barbara Hackman	Director	Sell	2,665	$77.26	$205,897.90
2/19/2014	Rajan Parmeswar	VP	Sell	3,600	$69.46	$250,056.00	3,829
12/30/2013	Mark Bertolini	CEO	Sell	130,272	$68.08	$8,868,917.76	526,938
12/27/2013	William James Casazza	VP	Sell	10,299	$68.25	$702,906.75	33,903
8/26/2013	William James Casazza	VP	Sell	15,745	$64.66	$1,018,071.70	33,903
6/18/2013	William James Casazza	VP	Sell	40,598	$62.00	$2,517,076.00
5/21/2013	Molly Joel Coye	Director	Sell	2,000	$60.38	$120,760.00
5/20/2013	Joseph P Newhouse	Director	Sell	14,000	$59.15	$828,100.00
5/15/2013	Rajan Parmeswar	VP	Sell	1,435	$60.13	$86,286.55
2/6/2013	Karen Rohan	VP	Buy	4,035	$49.53	$199,853.55

(Data available from 1/1/2013 forward)

Aetna (NYSE AET) News Headlines

Source:

Date	Headline
	Aetna Opens Support Lines to the Public Following Shooting at Noblesville West Middle School in Indiana finance.yahoo.com - May 26 at 8:23 AM
	Free Research Report as Aetna's Adjusted Earnings Jumped 14% finance.yahoo.com - May 25 at 8:20 AM
	Aetna, still looking for scapegoat in HIV disclosure fiasco, sues plaintiffs firms www.reuters.com - May 24 at 5:40 PM
	Insurance Goliath Sues Lawyers Representing HIV Patients For Aetna's Own Privacy Breach, says Consumer Watchdog www.prnewswire.com - May 24 at 3:18 PM
	Cantor Fitzgerald Remains Bullish on Aetna (AET) www.streetinsider.com - May 23 at 5:34 PM
	Research Analysts Set Expectations for Aetna's FY2018 Earnings (AET) www.americanbankingnews.com - May 23 at 7:14 AM
	Aetna (AET) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - May 21 at 1:36 AM
	Aetna (AET) Declares $0.50 Quarterly Dividend; 1.1% Yield www.streetinsider.com - May 20 at 5:43 PM
	Aetna (AET) Announces $0.50 Quarterly Dividend www.americanbankingnews.com - May 18 at 3:28 PM
	Aetna Annual Meeting Of Shareholders At 9:30 AM ET www.nasdaq.com - May 18 at 9:27 AM
	Brokerages Anticipate Aetna (AET) Will Announce Quarterly Sales of $15.51 Billion www.americanbankingnews.com - May 17 at 1:56 AM
	Stock Traders Purchase High Volume of Put Options on Aetna (AET) www.americanbankingnews.com - May 16 at 6:36 AM
	Brokerages Expect Aetna (AET) to Post $3.12 Earnings Per Share www.americanbankingnews.com - May 15 at 9:22 PM
	Correction: CVS is buying Aetna www.ft.com - May 15 at 8:09 AM
	Value-based health care focuses on quality outcomes www.bizjournals.com - May 14 at 5:31 PM
	Aetna (AET) Given New $194.00 Price Target at Credit Suisse Group www.americanbankingnews.com - May 14 at 5:24 PM
	Aetna (AET) Trump Proposal Unlikely To Impact Managed Care - Cantor Fitzgerald www.streetinsider.com - May 14 at 9:35 AM
	From Consultant To First Time CMO: Aetna's New Marketing Head Shares Some Insights www.forbes.com - May 11 at 5:52 PM
	Aetna (AET) Expected to Post Q2 2018 Earnings of $3.22 Per Share www.americanbankingnews.com - May 10 at 7:16 AM
	Piper Jaffray Comments on Aetna's Q2 2018 Earnings (AET) www.americanbankingnews.com - May 9 at 8:39 AM
	Free Post Earnings Research Report: Centene’s Revenue Jumped 13%; Adjusted EPS Soared 94% finance.yahoo.com - May 9 at 8:22 AM
	Aetna (AET) to Post Q2 2018 Earnings of $2.94 Per Share, Jefferies Group Forecasts www.americanbankingnews.com - May 7 at 2:46 AM
	Berkshire Hathaway, Amazon and JPMorgan Are Close to Hiring a CEO for Their Healthcare Venture finance.yahoo.com - May 6 at 8:26 AM
	Aetna Shareholder Meeting to Be Webcast finance.yahoo.com - May 4 at 5:37 PM
	Jefferies Group Weighs in on Aetna's FY2018 Earnings (AET) www.americanbankingnews.com - May 4 at 8:40 AM
	Aetna Forecasted to Post Q3 2018 Earnings of $2.88 Per Share (AET) www.americanbankingnews.com - May 4 at 8:11 AM
	Aetna (AET) Upgraded at Zacks Investment Research www.americanbankingnews.com - May 3 at 9:52 PM
	Health Insurers Had Their Best Quarter in Years, Despite the Flu finance.yahoo.com - May 3 at 5:31 PM
	Aetna Forecasted to Earn Q2 2018 Earnings of $3.32 Per Share (AET) www.americanbankingnews.com - May 3 at 9:11 AM
	CVS 'Moving Forward' With Aetna Deal www.bloomberg.com - May 3 at 8:23 AM
	CVS Says Aetna Merger 'Making Good Progress' On Regulatory Front finance.yahoo.com - May 2 at 5:31 PM
	CVS Says It’s Still ‘Moving Forward’ With $68 Billion Aetna Deal finance.yahoo.com - May 2 at 5:31 PM
	IIROC Trading Resumption - AET; MGX.P finance.yahoo.com - May 2 at 5:31 PM
	Critical Comparison: Trupanion (TRUP) and Aetna (AET) www.americanbankingnews.com - May 2 at 1:50 PM
	CVS 'Moving Forward' With Aetna Deal, Profit Tops Estimates www.bloomberg.com - May 2 at 8:03 AM
	CVS Health profit rises 4.8 pct finance.yahoo.com - May 2 at 8:02 AM
	[$$] CVS Gets a Lift From Prescriptions finance.yahoo.com - May 2 at 8:02 AM
	CVS Is `Moving Forward' With Aetna Deal as Profit Tops Estimates finance.yahoo.com - May 2 at 8:02 AM
	CVS Health beats expectations for 1Q, 2018 forecast marketbeat.com - May 2 at 7:25 AM
	Aetna (AET) Raised to Overweight at Cantor Fitzgerald www.americanbankingnews.com - May 1 at 5:28 PM
	Aetna Inc (AET) Slims and Trims Before Marriage to CVS investorplace.com - May 1 at 12:00 PM
	Aetna (AET) Issues Quarterly Earnings Results www.americanbankingnews.com - May 1 at 9:42 AM
	Earnings Reaction History: Aetna, 30.0% Follow-Through Indicator, 1.2% Sensitive www.nasdaq.com - May 1 at 8:00 AM
	Aetna Turns To Profit In Q1, Adj. Profit Tops View www.nasdaq.com - May 1 at 8:00 AM
	BRIEF-Aetna Says Recorded Operating Expense Of $233 Mln For March Quarter www.reuters.com - May 1 at 8:00 AM
	BRIEF-Aetna Reports Q1 Earnings Per Share $3.67 www.reuters.com - May 1 at 8:00 AM
	4 Things to Expect in CVS Health's Q1 Earnings Results finance.yahoo.com - May 1 at 8:00 AM
	Aetna Reports First-Quarter 2018 Results finance.yahoo.com - May 1 at 8:00 AM
	Aetna (AET) Q1 Earnings Top, Revenues Miss Estimates finance.yahoo.com - May 1 at 8:00 AM
	Aetna beats profit expectations, but sales come up a bit shy finance.yahoo.com - May 1 at 8:00 AM

Aetna (NYSE:AET) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Aetna (NYSE:AET) Income Statement, Balance Sheet and Cash Flow Statement

Aetna (NYSE AET) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff